1 |
van der Kaay DCM, Rochtus A, Binder G, Kurth I, Prawitt D, Netchine I, Johannsson G, Hokken-Koelega ACS, Elbracht M, Eggermann T. Comprehensive genetic testing approaches as the basis for personalized management of growth disturbances: current status and perspectives. Endocr Connect 2022;11:e220277. [PMID: 36064195 DOI: 10.1530/EC-22-0277] [Reference Citation Analysis]
|
2 |
Loid P, Lipsanen-nyman M, Ala-mello S, Hannula-jouppi K, Kere J, Mäkitie O, Muurinen M. Case report: A novel de novo IGF2 missense variant in a Finnish patient with Silver-Russell syndrome. Front Pediatr 2022;10:969881. [DOI: 10.3389/fped.2022.969881] [Reference Citation Analysis]
|
3 |
Baba N, Lengyel A, Pinti E, Yapici E, Schreyer I, Liehr T, Fekete G, Eggermann T. Microdeletions in 1q21 and 8q12.1 depict two additional molecular subgroups of Silver-Russell syndrome like phenotypes. Mol Cytogenet 2022;15:19. [PMID: 35562807 DOI: 10.1186/s13039-022-00596-z] [Reference Citation Analysis]
|
4 |
Mackay DJG, Temple IK. Ongoing Challenges in the Diagnosis of 11p15.5-Associated Imprinting Disorders. Mol Diagn Ther 2022;26:263-72. [PMID: 35522427 DOI: 10.1007/s40291-022-00587-1] [Reference Citation Analysis]
|